Journal
PAIN
Volume 104, Issue 3, Pages 437-447Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/S0304-3959(03)00051-4
Keywords
morphine tolerance; neonatal; glutamate; N-methyl-D-aspartate; ventral root potential
Categories
Funding
- NIDA NIH HHS [DA00325, DA06600] Funding Source: Medline
Ask authors/readers for more resources
N-methyl-D-aspartate (NMDA) receptor antagonists are effective in inhibiting the development of morphine tolerance in adult rats. But NMDA receptors undergo dramatic change during the first few weeks of the postnatal life in the rat. and it is unknown whether NMDA receptor antagonists can inhibit the acquisition of opiate tolerance in the developing organism. Here, we investigated the effects of two NMDA receptor antagonists MK-801 and dextromethorphan on the development of morphine tolerance in 7- 14-, and 21-day-old rats. NMDA receptor antagonists are not effective in attenuating morphine tolerance in the neonatal rat whereas they were partially effected in the 14-day-old and fully effective in rats as old or older than 21 days of age. These data suggest that there exists a transition age, around the second postnatal week in the rat, for the NMDA receptor to play a role in the development of morphine tolerance. (C) 2003 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available